α-Tocopherol administration produces an antidepressant-like effect in predictive animal models of depression

Behavioural Brain Research

Volumn 209, Issue 2, 2010, Pages 249-259

  Lobato, Kelly R ^a   Cardoso, Chandra C ^a   Binfaré, Ricardo W ^a   Budni, Josiane ^a   Wagner, Cristiane L R ^a   Brocardo, Patrícia S ^a   de Souza, Luiz Felipe ^a   Brocardo, Caroline ^a   Flesch, Samira ^a   Freitas, Andiara E ^a   Dafré, Alcir L ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Tocopherol; Tocopheryl phosphate; Forced swimming test; Glutathione; Tail suspension test

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOPHERYL PHOSPHATE; FLUOXETINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN LEVEL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEPRESSION; DISEASE MODEL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; ENZYME ACTIVITY; EXPERIMENTAL TEST; FEMALE; FORCED SWIMMING TEST; HIPPOCAMPUS; IMMOBILITY TIME; LOCOMOTION; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; TAIL SUSPENSION TEST; TIME;

ALPHA-TOCOPHEROL; ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; FLUOXETINE; GLUTATHIONE; HINDLIMB SUSPENSION; HIPPOCAMPUS; IMMOBILITY RESPONSE, TONIC; MICE; MOTOR ACTIVITY; PREFRONTAL CORTEX; SWIMMING; TIME FACTORS;

EID: 77649235136     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.02.002     Document Type: Article

References (61)

1. Azzi A. The role of alpha-tocopherol in preventing disease. Eur J Nutr 43 (2004) 18-25
2. Azzi A. Molecular mechanism of alpha-tocopherol action. Free Radic Biol Med 43 (2007) 16-21
3. Barauna S.C., Kaster M.P., Heckert B.T., do Nascimento K.S., Rossi F.M., Teixeira E.H., et al. Antidepressant-like effect of lectin from Canavalia brasiliensis (ConBr) administered centrally in mice. Pharmacol Biochem Behav 85 (2006) 160-169
4. Berg B.M., Godbout J.P., Kelley K.W., and Johnson R.W. Alpha-tocopherol attenuates lipopolysaccharide-induced sickness behavior in mice. Brain Behav Immun 18 (2004) 149-157
5. Berk M., Copolov D.L., Dean O., Lu K., Jeavons S., Schapkaitz I., et al. N-acetyl cysteine for depressive symptoms in bipolar disorder-a double-blind randomized placebo-controlled trial. Biol Psychiatry 64 (2008) 468-475
6. Berk M., Ng F., Dean O., Dodd S., and Bush A.I. Glutathione: a novel treatment target in psychiatry. Trends Pharmacol Sci 29 (2008) 346-351
7. Berton O., and Nestler E.J. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7 (2006) 137-151
8. Bilici M., Efe H., Köroǧlu M.A., Uydu H.A., Bekaroǧlu M., and Deǧer O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 64 (2001) 43-51
9. Borsini F., and Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 94 (1988) 147-160
10. Bourin M., Chenu F., Ripoll N., and David D.J. A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests. Behav Brain Res 164 (2005) 266-269
11. Bourre J.M. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2. Macronutrients. J Nutr Health Aging 10 (2006) 386-399
12. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
13. Brigelius-Flohé R. Vitamin E: the shrew waiting to be tamed. Free Radic Biol Med 46 (2009) 543-554
14. Brigelius-Flohé R., and Traber M.G. Vitamin E: function and metabolism. FASEB J 13 (1999) 1145-1155
15. Brocardo P.S., Budni J., Kaster M.P., Santos A.R.S., and Rodrigues A.L.S. Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Neuropharmacology 54 (2008) 464-473
16. Carlberg I., and Mannervik B. Glutathione reductase. Methods Enzymol 113 (1985) 484-490
17. Cryan J.F., Markou A., and Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23 (2002) 238-245
18. Cryan J.F., Page M.E., and Lucki I. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology 182 (2005) 335-344
19. Detke M.J., Johnson J., and Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 5 (1997) 107-112
20. Devaraj S., and Jialal I. Antioxidants and vitamins to reduce cardiovascular disease. Curr Atheroscler Rep 2 (2000) 342-351
21. Dotan Y., Lichtenberg D., and Pinchuk I. No evidence supports vitamin E indiscriminate supplementation. Biofactors 35 (2009) 469-473
22. Dringen R., and Hirrlinger J. Glutathione pathways in the brain. Biol Chem 384 (2003) 505-516
23. Eren I., Naziroǧlu M., and Demirdaş A. Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochem Res 32 (2007) 1188-1195
24. Eren I., Naziroglu M., Demirdas A., Celik O., Uguz A.C., Altunbasak A., et al. Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat. Neurochem Res 32 (2007) 497-505
25. Gianello R., Libinaki R., Azzi A., Gavin P.D., Negis Y., Zingg J.M., et al. α-Tocopheryl phosphate: a novel, natural form of vitamin E. Free Radic Biol Med 39 (2005) 970-976
26. Godbout J.P., Berg B.M., Krzyszton C., and Johnson R.W. Alpha-tocopherol attenuates NFkappaB activation and pro-inflammatory cytokine production in brain and improves recovery from lipopolysaccharide-induced sickness behavior. J Neuroimmunol 169 (2005) 97-105
27. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 97 (2006) 1634-1658
28. Hathcock J.N., Azzi A., Blumberg J., Bray T., Dickinson A., Frei B., et al. Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr 81 (2005) 736-745
29. Herken H., Gurel A., Selek S., Armutcu F., Ozen M.E., Bulut M., et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 38 (2007) 247-252
30. Kaster M.P., Budni J., Binfaré R.W., Santos A.R.S., and Rodrigues A.L.S. The inhibition of different types of potassium channels underlies the antidepressant-like effect of adenosine in the mouse forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 690-696
31. Khanzode S.D., Dakhale G.N., Khanzode S.S., Saoji A., and Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep 8 (2003) 365-370
32. Machado D.G., Kaster M.P., Binfaré R.W., Dias M., Santos A.R.S., Pizzolatti M.G., et al. Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 421-428
33. Maes M., De Vos N., Pioli R., Demedts P., Wauters A., Neels H., et al. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord 58 (2000) 241-246
34. McArthur R., and Borsini F. Animal models of depression in drug discovery: a historical perspective. Pharmacol Biochem Behav 84 (2006) 436-452
35. Negis Y., Zingg J.M., Ogru E., Gianello R., Libinaki R., and Azzi A. On the existence of cellular tocopheryl phosphate, its synthesis, degradation and cellular roles: a hypothesis. IUBMB Life 57 (2005) 23-25
36. Nemeroff C.B. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psychiatr Res 41 (2007) 189-206
37. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
38. Ogru E., Libinaki R., Gianello R., West S., Munteanu A., Zingg J.M., et al. Modulation of cell proliferation and gene expression by alpha-tocopheryl phosphates: relevance to atherosclerosis and inflammation. Ann N Y Acad Sci 1031 (2004) 405-411
39. Owen A.J., Batterham M.J., Probst Y.C., Grenyer B.F., and Tapsell L.C. Low plasma vitamin E levels in major depression: diet or disease?. Eur J Clin Nutr 59 (2005) 304-306
40. Ozcan M.E., Gulec M., Ozerol E., Polat R., and Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 19 (2004) 89-95
41. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229 (1977) 327-336
42. Reiter E., Jiang Q., and Christen S. Anti-inflammatory properties of α and γ tocopherol. Mol Aspects Med 28 (2007) 668-691
43. Ricciarelli R., Zingg J.M., and Azzi A. Vitamin E 80th anniversary: a double life, not only fighting radicals. IUBMB Life 52 (2001) 71-76
44. Rodrigues A.L.S., Silva G.L., Matteussi A.S., Fernandes E., Miguel O., Yunes R.A., et al. Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci 70 (2002) 1347-1358
45. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 82 (1997) 291-295
46. Singh U., Devaraj S., and Jialal I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 25 (2005) 151-174
47. Schmidt A.J., Heiser P., Hemmeter U.M., Krieg J.C., and Vedder H. Effects of antidepressants on mRNA levels of antioxidant enzymes in human monocytic U-937 cells. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 1567-1573
48. Schneider C. Chemistry and biology of vitamin E. Mol Nutr Food Res 49 (2005) 7-30
49. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85 (1985) 367-370
50. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Ana Biochem 27 (1969) 502-522
51. Traber M.G., and Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med 43 (2007) 4-15
52. Traber M.G., Frei B., and Beckman J.S. Vitamin E revisited: do new data validate benefits for chronic disease prevention?. Curr Opin Lipidol 19 (2008) 30-38
53. Tsuboi H., Shimoi K., Kinae N., Oguni I., Hori R., and Kobayashi F. Depressive symptoms are independently correlated with lipid peroxidation in a female population: comparison with vitamins and carotenoids. J Psychosom Res 56 (2004) 53-58
54. Tsuboi H., Tatsumi A., Yamamoto K., Kobayashi F., Shimoi K., and Kinae N. Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants. J Affect Disord 91 (2006) 63-70
55. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39 (2007) 44-84
56. Van Haaften R.I., Haenen G.R., Evelo C.T., and Bast A. Effect of vitamin E on glutathione-dependent enzymes. Drug Metab Rev 35 (2003) 215-253
57. Wendel A. Glutathione peroxidase. Methods Enzymol 77 (1981) 325-333
58. Wong M.L., and Licinio J. Research and treatment approaches to depression. Nat Rev Neurosci 2 (2001) 343-351
59. Yanik M., Erel O., and Kati M. The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatrica 16 (2004) 200-203
60. Zafir A., and Banu N. Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats. Eur J Pharmacol 572 (2007) 23-31
61. Zafir A., Ara A., and Banu N. In vivo antioxidant status: a putative target of antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry 33 (2009) 220-228